Sarah Elizabeth Bohndiek is a physicist whose research involves developing novel imaging approaches for early cancer detection. She is a Professor in Biomedical Physics at the University of Cambridge [1] and a Group Leader at the Cancer Research UK Cambridge Institute. [2] [3]
Bohndiek received her BA in Experimental and Theoretical Physics from the University of Cambridge in 2005. She then went on to complete a PhD in Radiation Physics at University College London in 2008, developing novel instrumentation for identification of cancer in breast biopsy samples using X-ray diffraction methods. [4] [5]
Following completion of her PhD, Bohndiek moved to the University of Cambridge where she worked as a postdoctoral research fellow at the Department of Biochemistry, supervised by Prof. Kevin Brindle. [5] Her research during this period focused on the use of novel magnetic resonance imaging methods for the early detection of treatment response in cancer.
In 2011, Bohndiek took the position of Postdoctoral Scholar at Stanford University's Department of Radiology, supervised by Prof. Sam Gambhir. [5]
In October 2013, Bohndiek returned to the University of Cambridge as a fellow of Corpus Christi College, working as a lecturer at the Cavendish Laboratory. [5]
Bohndiek's research at the Cancer Research UK Cambridge Institute has focused on devising new imaging approaches to improve early cancer diagnosis. [6] [7] One project is using hyperspectral imaging in endoscopy to map early metabolic changes in the oesophagus before cancer occurs, giving an early indication of the potential for developing the cancer. [8] [9] [10] [11]
Bohndiek is co-lead of CRUK Cambridge Centre Early Detection Programme [12] along with Rebecca Fitzgerald.
Bohndiek actively promotes science as a career, working with the Stemettes, MentorSET and engaging with media and public outreach. [13] [14]
Bohndiek was awarded the 2014 WISE Research Award sponsored by the Institution of Engineering and Technology and the Wellcome Trust. [15] [16] This award is given for groundbreaking scientific research by a female-led team. [17]
In 2014 Bohndiek also received the Clifford Paterson Medal and Prize, [18] which is awarded by the Institute of Physics for early career contributions to the application of physics in an industrial or commercial context. [19] She received this award for her work in developing molecular imaging techniques, which can be applied to study the response of tissue to different cancer treatments. [20]
Recognising her commitment to teaching and mentoring, Bohndiek was also awarded the Marie Skłodowska-Curie Prize for Nurturing Research Talent [21] [22] and a Suffrage Science Heirloom by the Medical Research Council. [23] [24] [25]
In 2018, Bohndiek was awarded the Cancer Research UK Future Leaders in Cancer Research Prize which recognises individuals who have produced research of international importance. [26]
The Institute of Physics (IOP) is a UK-based learned society and professional body that works to advance physics education, research and application.
Cancer Research UK (CRUK) is the world's largest independent cancer research organization. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.
The Christie NHS Foundation Trust in Withington, Manchester, manages the Christie Hospital, one of the largest cancer treatment centres of its type in Europe. The Christie became an NHS Foundation Trust in 2007 and is also an international leader in cancer research and development, home to the Paterson Institute for Cancer Research.
The Isaac Newton Medal and Prize is a gold medal awarded annually by the Institute of Physics (IOP) accompanied by a prize of £1,000. The award is given to a physicist, regardless of subject area, background or nationality, for outstanding contributions to physics. The award winner is invited to give a lecture at the Institute. It is named in honour of Sir Isaac Newton.
Henry James Snaith is a professor in physics in the Clarendon Laboratory at the University of Oxford. Research from his group has led to the creation of a new research field, based on halide perovskites for use as solar absorbers. Many individuals who were PhD students and postdoctoral researchers in Snaith's group have now established research groups, independent research portfolios and commercial enterprises. He co-founded Oxford Photovoltaics in 2010 to commercialise perovskite based tandem solar cells.
The Katharine Burr Blodgett Medal and Prize is a gold medal awarded annually by the Institute of Physics to "recognise contributions to the organisation or application of physics in an industrial or commercial context." The medal is accompanied by a prize of £1000.
Rachel Anne McKendry is a British chemist. She is Director of i-sense, a UK-based interdisciplinary research collaboration developing early warning sensing systems for infectious diseases, and was part of the UK's Cross Council Initiative on Antimicrobial Resistance. McKendry is also Professor of Biomedical Nanoscience at University College London, holding a joint appointment in the Division of Medicine and the London Centre for Nanotechnology.
Sheila Rowan is a Scottish physicist and academic, who is Professor of Physics and Astronomy at the University of Glasgow in Scotland, and director of its Institute for Gravitational Research since 2009. She is known for her work in advancing the detection of gravitation waves. In 2016, Rowan was appointed the (part-time) Chief Scientific Advisor to the Scottish Government.
Hiranya Vajramani Peiris is a British astrophysicist at University College London and Stockholm University, best known for her work on the cosmic microwave background radiation. She was one of 27 scientists who received the Breakthrough Prize in Fundamental Physics in 2018 for their "detailed maps of the early universe."
Caroline Dive is a British cancer research scientist. Dive is Professor of Cancer Pharmacology at the University of Manchester, Deputy Director of the Cancer Research UK (CRUK) Manchester Institute, Director of the CRUK Manchester Institute Cancer Biomarker Centre and co-director of the CRUK Lung Cancer Centre of Excellence. She is the current President of The European Association for Cancer Research (EACR).
Valerie Gibson, also known as Val Gibson, is a professor of Physics and Head of the High Energy Physics group at the University of Cambridge.
Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.
(Robert) Charles Swanton is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.
Sir Ian Trevelyan Chapman is a British physicist who is the chief executive of the United Kingdom Atomic Energy Authority (UKAEA).
Rebecca Clare Fitzgerald is a British medical researcher whose work focuses on the early detection and treatment of oesophageal cancers. She is a tenured Professor of Cancer Prevention and Program Leader at the Medical Research Council Cancer Unit of the University of Cambridge. In addition to her professorship, Fitzgerald is currently the Director of Medical Studies for Trinity College, Cambridge, where she is also a Fellow. She is also an Honorary Consultant in Gastroenterology and General Medicine at Cambridge's Addenbrooke's Hospital. She is also the co-leader of the CRUK Cambridge Institute Early Detection Programme.
Professor Richard James Gilbertson is a paediatric oncology clinician scientist and a Senior Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge. He is the Li Ka Shing Chair of Oncology, and Director of the CRUK Cambridge Major Centre and the Children's Brain Tumour Centre of Excellence.
The Clifford Paterson Medal and Prize is awarded by the Institute of Physics. It was established in 1981 and named after Clifford Copland Paterson. The prize is awarded each year for exceptional early career contributions to the application of physics in an industrial or commercial context. The medal is bronze and is accompanied by a prize of £1000 and a certificate.
The James Joule Medal and Prize is awarded by the Institute of Physics. It was established in 2008, and was named in honour of James Prescott Joule, British physicist and brewer. The award is made for distinguished contributions to applied physics. The medal is silver and is accompanied by a prize of £1000.
Victoria Sanz Moreno is a Spanish scientist. She is professor of cancer cell biology at Queen Mary University of London.
Sarah Blagden is a Professor of Experimental Oncology at the University of Oxford. Her laboratory research is in investigating post-transcriptional mechanisms for ovarian cancer behavior. Her clinical research is in conducting early phase trials in novel cancer therapeutics for people with advanced malignancies.